The investigational subcutaneous hepcidin mimetic peptide is designed to regulate iron and red blood cell production
SLE remains a life-threatening autoimmune disease, with patients facing an elevated risk of early mortality and long-term organ damage
WuXi Biologics has integrated sustainability principles throughout its supplier lifecycle management
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India’s pharmaceutical sector stands at a pivotal inflection point
The company previously completed a $150 million venture investment, acquisition, and recapitalization
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
Our scientists found that toxicological data for most PFAS are incomplete or unavailable, leaving significant uncertainty about consumer safety
Syrma Johari is a globally recognised medical device engineering and manufacturing organisation
The approval is supported by data from three pivotal clinical trials
Subscribe To Our Newsletter & Stay Updated
